These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10687269)

  • 1. [Mefloquine and ototoxicity: a report of 3 cases].
    Fusetti M; Eibenstein A; Corridore V; Hueck S; Chiti-Batelli S
    Clin Ter; 1999; 150(5):379-82. PubMed ID: 10687269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible hearing loss in temporal association with chemoprophylactic mefloquine use.
    Wise M; Toovey S
    Travel Med Infect Dis; 2007 Nov; 5(6):385-8. PubMed ID: 17983978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine.
    Clattenburg RN; Donnelly CL
    J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1606-8. PubMed ID: 9394947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychopathological phenomena in long-term follow-up of acute psychosis after preventive mefloquinine (Lariam) administration].
    Meszaros K; Kasper S
    Nervenarzt; 1996 May; 67(5):404-6. PubMed ID: 9005352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropsychiatric side effects of malarial prophylaxis with mefloquine (Lariam)].
    Minei-Rachmilewitz T
    Harefuah; 1999 Jul; 137(1-2):25-7, 87. PubMed ID: 10959270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-frequency testing techniques and instrumentation for early detection of ototoxicity.
    Fausti SA; Frey RH; Henry JA; Olson DJ; Schaffer HI
    J Rehabil Res Dev; 1993; 30(3):333-41. PubMed ID: 8126658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropsychiatric symptoms in preventive antimalarial treatment with mefloquine: apropos of 2 cases].
    Lebain P; Juliard C; Davy JP; Dollfus S
    Encephale; 2000; 26(4):67-70. PubMed ID: 11064842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mefloquine-induced pneumonitis.
    Soentjens P; Delanote M; Van Gompel A
    J Travel Med; 2006; 13(3):172-4. PubMed ID: 16706949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A severe adverse reaction to mefloquine and chloroquine prophylaxis.
    Lysack JT; Lysack CL; Kvern BL
    Aust Fam Physician; 1998 Dec; 27(12):1119-20. PubMed ID: 9919736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mood disorder after malaria prophylaxis with mefloquine (two case reports)].
    Oueriagli Nabih F; Touhami M; Laffinti A; Abilkacem L
    Encephale; 2011 Oct; 37(5):393-6. PubMed ID: 22032283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropsychiatric symptoms caused by mefloquine (report of several cases)].
    Murai Z; Baran B; Tolna J; Szily E; Gazdag G
    Orv Hetil; 2005 Jan; 146(3):133-6. PubMed ID: 15693445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The ototoxicity of cisplatin: a clinical study].
    Vantrappen G; Rector E; Debruyne F
    Acta Otorhinolaryngol Belg; 1990; 44(4):415-21. PubMed ID: 2093285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration.
    Reddel RR; Kefford RF; Grant JM; Coates AS; Fox RM; Tattersall MH
    Cancer Treat Rep; 1982 Jan; 66(1):19-23. PubMed ID: 7198012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paranoid psychosis related to mefloquine antimalarial prophylaxis.
    Fuller SJ; Naraqi S; Gilessi G
    P N G Med J; 2002; 45(3-4):219-21. PubMed ID: 12968793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hearing in workers exposed to low-dose radiation for a long period.
    Karlidağ T; Kaygusuz I; Keleş E; Yalçin S; Serhatlioğlu SS; Açik Y; Oztürk L
    Hear Res; 2004 Aug; 194(1-2):60-4. PubMed ID: 15276676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maculopathy associated with mefloquine (Lariam) therapy for malaria prophylaxis.
    Walker RA; Colleaux KM
    Can J Ophthalmol; 2007 Feb; 42(1):125-6. PubMed ID: 17361254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [There is no evidence of more symptoms with mefloquine than with other drugs in malaria prophylaxis].
    Cobelens FG; van Thiel PP
    Ned Tijdschr Geneeskd; 1997 Apr; 141(16):794-5; author reply 796. PubMed ID: 9213805
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombotic-thrombocytopenic purpura following malaria prophylaxis with mefloquine.
    Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Cabassi A; Ariya K; Wirote L
    J Antimicrob Chemother; 2006 Jan; 57(1):160-1. PubMed ID: 16286357
    [No Abstract]   [Full Text] [Related]  

  • 19. Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions.
    Bem JL; Kerr L; Stuerchler D
    J Trop Med Hyg; 1992 Jun; 95(3):167-79. PubMed ID: 1597872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mefloquine-induced eosinophilic pneumonia.
    Katsenos S; Psathakis K; Nikolopoulou MI; Constantopoulos SH
    Pharmacotherapy; 2007 Dec; 27(12):1767-71. PubMed ID: 18041895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.